Beryl Drugs Limited announced unaudited earnings results for the second quarter ended September 30, 2018. For the quarter, the company reported total revenue from operations of INR 35,959,000 against INR 32,398,000 a year ago. Profit from operations before exceptional and extraordinary items and tax was INR 2,549,000 compared to INR 1,158,000 a year ago. Profit before was INR 2,549,000 compared to INR 5,726,000 a year ago. Net profit for the period after tax was INR 1,408,000 or INR 0.280 basic and diluted per share before and after extraordinary items against INR 5,426,000 or INR 1.070 basic and diluted per share before and after extraordinary items a year ago. For the half year, the company reported total revenue from operations of INR 77,832,000 against INR 81,246,000 a year ago. Profit from operations before exceptional and extraordinary items and tax was INR 5,073,000 compared to INR 2,445,000 a year ago. Profit before tax was INR 5,073,000 compared to INR 7,013,000 a year ago. Net profit for the period was INR 3,432,000 or INR 0.68 basic and diluted per share before and after extraordinary items against INR 6,393,000 or INR 1.26 basic and diluted per share before and after extraordinary items a year ago.